Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1798]

Advances in advanced prostate cancer from ESMO 2012; focus on abiraterone...

Dr Chris Parker , Dr Charles Ryan, Prof Karim Fizazi

Advances in advanced prostate cancer from ESMO 2012; focus on abiraterone acetate ( Dr Chris Parker , Dr Charles Ryan, Prof Karim Fizazi )

Putting the theory of personalised medicine into practice

Prof Fabrice Andre, Dr Ramesh Ramanathan, Prof Peter Harper and Prof Robert...

Putting the theory of personalised medicine into practice ( Prof Fabrice Andre, Dr Ramesh Ramanathan, Prof Peter Harper and Prof Robert Leonard )

Treatment of ALK+ lung cancer with crizotinib, Profile 1007

Dr Alice Shaw – Massachusetts General Hospital, Boston, USA

The first phase II trial for the management of oesophageal cancer

Prof David Ferry – New Cross Hospital, Wolverhampton, UK

The first phase II trial for the management of oesophageal cancer ( Prof David Ferry – New Cross Hospital, Wolverhampton, UK )

Phase III MISSION trial: Sorafenib does not extend overall survival as third or...

Dr Tony Mok – The Chinese University of Hong Kong

Phase III MISSION trial: Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer ( Dr Tony Mok – The Chinese University of Hong Kong )

Personalised cancer medicine and research: Today’s best practice

Prof José Baselga - Massachusetts General Hospital, Boston, USA

Personalised cancer medicine and research: Today’s best practice ( Prof José Baselga - Massachusetts General Hospital, Boston, USA )

Putting drugs to work against brain metastases in HER2 positive breast cancer:...

Dr Thomas Bachelot – Centre Leon Berard, Lyon

Putting drugs to work against brain metastases in HER2 positive breast cancer: LANDSCAPE study ( Dr Thomas Bachelot – Centre Leon Berard, Lyon )

Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK...

Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA

Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer ( Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA )

Key topics from day 2 of the 10th International Workshop on Non-Hodgkin's...

Dr Wyndham Wilson - National Cancer Institute, Bethesda, MD, USA; Prof. Owen...

Key topics from day 2 of the 10th International Workshop on Non-Hodgkin's Lymphoma ( Dr Wyndham Wilson - National Cancer Institute, Bethesda, MD, USA; Prof. Owen O’Conner – New York University Cancer Institute and Lagone Medical Centre; Dr Myron Czuczman - Roswell Park Cancer Institute, Buffalo, NY, USA; Prof John Gribben - Bart’s and )

Highlights from the 17th International Conference on Cancer Nursing

Greta Cummings – President of the International Society of Nurses of Cancer Care

Highlights from the 17th International Conference on Cancer Nursing ( Greta Cummings – President of the International Society of Nurses of Cancer Care )

ASCO / ONS Chemotherapy Standards

Kris LeFebvre – Oncology Nursing Society, Pittsburgh, USA

ASCO / ONS Chemotherapy Standards ( Kris LeFebvre – Oncology Nursing Society, Pittsburgh, USA )

Best practice in nurse-led chemotherapy, standardising services, as well as...

Elaine Lennan – University Hospital Southampton NHS Foundation Trust, UK

Best practice in nurse-led chemotherapy, standardising services, as well as electronic prescriptions and nurse-physician communication ( Elaine Lennan – University Hospital Southampton NHS Foundation Trust, UK )

More from ecancer